Application of static integrated skeletal reduction and tabulation of dynamic adaptive chemistry in the combustion simulation of ethylene-fueled scramjet combustor.

The high-fidelity reduced mechanism is one of the key elements in the combustion simulation of scramjet combustors to reveal their combustion and flow phenomena. In the present work, the hierarchically constructed NUIGMech1.2 (2857 species and 11 814 reactions) is applied to the combustion simulation of an ethylene-fueled scramjet combustor using the method of static integrated skeletal reduction and tabulation of dynamic adaptive chemistry (TDAC). The integrated skeletal reduction strategy successively consists of species elimination using the revised directed relation graph with error propagation method of fixed species scheme and improved sensitivity analysis method, and reactions elimination based on computational singular perturbation importance index. A preferred ethylene skeletal mechanism (26 species and 117 reactions) is obtained through the integrated skeletal reduction strategy under target working conditions of temperature range of 900-1800 K, pressure range of 1-4 atm, and equivalence ratio range of 0.25-5.0. The compact skeletal mechanism is comprehensively validated against the experimental results of ignition delay times, laminar flame speeds, and key species concentration profiles. Meanwhile, it shows consistent results with the detailed mechanism on the adiabatic flame temperature profiles and "S"-curves. When applying this skeletal mechanism to combustion simulations of ethylene-fueled scramjet combustor with double parallel cavities, the path flux analysis method and in situ adaptive tabulation algorithm of TDAC is further utilized to speed up the chemical reaction solution process at run-time. Under the scramjet and ramjet modes, the corresponding simulation results in terms of flame luminosity images, schlieren images, and static pressure distributions, coincide well with those of experimental measurements. The combustion and flow characteristics of the two modes are investigated and analyzed comparatively based on above results and combustion performance parameters. Present work contributes to the application of fuel kinetic mechanisms in scramjet combustor combustion simulation.

Naphtho[1,8-ef]isoindole-7,8,10(9H)-trione as Novel Theranostic Agents for Photodynamic Therapy and Multi-Subcellular Organelles Localization.

A series of naphtho[1,8-ef]isoindole-7,8,10(9H)-trione derivatives as novel theranostic agents for photodynamic therapy and multi-subcellular organelles localization were designed and synthesized. Most of them possess moderate fluorescence quantum yield and long wavelength absorption simultaneously, which made them possible for dual effects of imaging and therapy. Notably, compounds 7 b and 7 d exhibited significant light-toxicity but slight dark-toxicity. Confocal fluorescence microscopy experiments demonstrated that compound 7 b can locate and image in special multi-subcellular organelles. All the research results implied that naphtho[1,8-ef] isoindole-7,8,10(9H)-trione derivatives can be applied as a new series of theranostic agents with the characteristics of photodynamic therapy and multi-subcellular organelles imaging.

eEF1A2 promotes PTEN-GSK3ß-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer.

The translation elongation factor eEF1A promotes protein synthesis. Its methylation by METTL13 increases its activity, supporting tumor growth. However, in some cancers, a high abundance of eEF1A isoforms is associated with a good prognosis. Here, we found that eEF1A2 exhibited oncogenic or tumor-suppressor functions depending on its interaction with METTL13 or the phosphatase PTEN, respectively. METTL13 and PTEN competed for interaction with eEF1A2 in the same structural domain. PTEN-bound eEF1A2 promoted the ubiquitination and degradation of the mitosis-promoting Aurora kinase A in the S and G2 phases of the cell cycle. eEF1A2 bridged the interactions between the SKP1-CUL1-FBXW7 (SCF) ubiquitin ligase complex, the kinase GSK3ß, and Aurora-A, thereby facilitating the phosphorylation of Aurora-A in a degron site that was recognized by FBXW7. Genetic ablation of Eef1a2 or Pten in mice resulted in a greater abundance of Aurora-A and increased cell cycling in mammary tumors, which was corroborated in breast cancer tissues from patients. Reactivating this pathway using fimepinostat, which relieves inhibitory signaling directed at PTEN and increases FBXW7 expression, combined with inhibiting Aurora-A with alisertib, suppressed breast cancer cell proliferation in culture and tumor growth in vivo. The findings demonstrate a therapeutically exploitable, tumor-suppressive role for eEF1A2 in breast cancer.